It's part of a program designed as an alternative to nursing home care for people who want to remain in their communities, ...

A union representing health care workers sued Kaiser in October 2021 claiming the medical provider was violating its ...

Tim Mok, PharmD, BCPS, BCOP, malignant hematology pharmacy research analyst at Kaiser Permanente, discussed his perspective on the balance between clinical outcomes and cost considerations.

The last round in 2021 valued the healthcare technology firm at $3.2 billion, more than doubling its valuation from $1.3 ...

A decrease in California's sexually transmitted infections (STIs) followed early real-world adoption of doxycycline ...

Health tech company Innovaccer secured a $275 million series F funding round to invest in artificial intelligence with the ...

The new study, which examined the largest cohort of doxyPEP recipients reported globally to date, used pharmacy data to ...

Innovaccer has raised $275 Mn in its Series F funding round from investors like B Capital Group, Banner Health, Danaher ...

This funding will support Innovaccer's efforts to expand collaboration with existing customers, introduce new AI and cloud ...

A new study in JAMA Internal Medicine led by the Harvard Pilgrim Health Care Institute examined whether doxycycline post-exposure prophylaxis (doxyPEP) was associated with declines in bacterial ...